spacer
home > epc > summer 2004 > dynamic modelling and simulation for nasal drug delivery
PUBLICATIONS
European Pharmaceutical Contractor

Dynamic Modelling and Simulation for Nasal Drug Delivery

Nasal drug delivery is rapidly emerging as a route for drug administration. Computer- aided engineering simulation tools, such as computational fluid dynamics (CFD), are extensively used across a wide range of industry sectors, and this same technology is now being used for the simulation of nasal air flow passages and the deposition of drug particles. This article presents a study in which CFD simulation technology was applied. For the study, air flow velocities and distribution profiles of the drug particles were mapped as they travelled through the nasal cavity geometry chosen for analysis. The study also looked at the effects of key drug system formulation variables, such as particle size and densities, on drug deposition. The results show that simulations can be effectively used for the optimisation of nasal drug delivery systems, thereby minimising experimental work and clinical trials.

Nasal drug delivery systems are quickly being recognised as a method of drug administration and are emerging as an alternative to oral and injection routes of delivery (1,2). Some of the key advantages of using the nasal administration route are the improved speed of the pharmacological action as a feature of improved accessibility to the vasculature, and the ability to achieve target-specific drug delivery. The key factors for efficacy and safety are the formulation, the distribution of the drug and the localised therapeutic concentrations. The nasal route of administration is influenced by the particular target zones for delivery, the residence time of the delivered pharmacologically active agent and the flow characteristics that occur as a consequence of the nasal geometry. However, the complexity of the nasal geometry presents a major challenge when attempting to ensure the administration of a replicable dose.

The impact of device design upon the efficacy, and consequently the safety of the system, is important to understand. For both device design and formulation development, it is crucial to understand how both the drug delivery system (that is the device) and the drug itself, would interact with the complex nasal geometry. For this study, a nasal geometry was obtained through a CT scan, which was then used to examine formulation variables and their interaction with the nasal cavity using the CFD simulation approach.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer
By Dr Jin Yan, Dr Atul Karanjkar and Martin Branagan, Healthcare Team at Fluent Europe Ltd

Dr Jin Yan is a Senior CFD Analyst at Fluent Europe Ltd working in Technical Services. He has a PhD in Thermodynamics from Durham University and has spent a total of five years at Fluent Europe working in both software and consultancy.

Dr Atul Karanjkar is Business Development Manager for Fluent Europe's Healthcare team. He has extensive experience within the health care industry in both Europe and North America. Dr Karanjkar has a PhD in Chemical Engineering and an MBA in Strategic Management.

Martin Branagan is Account Manager for Fluent Europe's Healthcare Team. He has over 12 years of health care industry experience through working at Smith & Nephew, where he was a Research Scientist, Project Manager and finally a Safety Consultant for the worldwide operations of the company, prior to joining Fluent.




spacer
Dr Jin Yan
spacer
spacer
spacer
Dr Atul Karanjkar
spacer
spacer
spacer
Martin Branagan
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Social Media in Pharmaceuticals

9-10 July 2012, London, UK

2012 is an exciting year for social media: the year social media goes viral. The pharmaceutical industry have been waiting for guidance from the FDA and now they have finally shed some light with their 'Off-Label Use' with some mention regarding social media. Although this is not directly aimed at social media, the fact that the FDA discusses social media demonstrates the importance.
More info >>

 
News and Press Releases

Worldwide Clinical Trials Inc acclaimed by Industry Standard Research as ‘The CRO to have on your radar’

Worldwide Clinical Trials Inc. (WCT), a leading global Clinical Research Organisation (CRO), is proud to announce that it has received strong ratings and recommendations across all areas of one of the industry’s leading reports into sector standards.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.